Advertisement

Topics

Companies Related to "Immunotherapeutics Immune Checkpoint Inhibitor Effi 24th Molecular 2017" [Most Relevant Company Matches] - Page: 20 RSS

19:53 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Immunotherapeutics Immune Checkpoint Inhibitor Effi 24th Molecular 2017" found in our extensive corporate database of over 50,000 company records.

Showing "Immunotherapeutics Immune Checkpoint Inhibitor Effi 24th Molecular 2017" Companies 476–500 of 1,900+

Probably Relevant

XTL Biopharmaceuticals

TL Biopharmaceuticals Ltd. ("XTL") is engaged in the acquisition, development and commercialization of therapeutics for the treatment of neuropathic pain and hepatitis C. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of neuropathic pain. XTL is also developing several novel pre-clinical hepatitis C small molecule inhibitors. XTL also has an acti...


Valify, Inc.

Valify, named as a Gartner “Cool Vendor” for Supply Chain Execution Technologies in 2017, is a purchased services technology solution that enables health care organizations to quickly identify spend, benchmark performance, and monitor savings in over 1,200 categories. With proprietary benchmarking analysis, market share insights, and customizable...

MacroGenics Inc.

MacroGenics, Inc. is developing immune-based products including monoclonal antibodies to treat patients with cancer, autoimmune disorders, allergy, or infectious diseases and vaccines to prevent infections in healthy individuals.


Karus Therapeutics

Karus Therapeutics is a leader in the development of innovative medicines that have breakthrough potential in treating inflammatory disease and cancer. The Company’s scientific excellence is reflected in its proprietary PI3K and HDAC6 inhibitor programmes, from which innovative small molecule drugs with significant clinical and commercial potential ha...

Multiplicom N.V.

Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine. The company was created in 2011 as a spin-off by the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. The successful intro...

Editas Medicine

Editas Medicine is a transformative genome editing company founded by five world leaders in the fields of genome editing, protein engineering, and molecular and structural biology, with specific expertise in CRISPR/Cas9 and TALENs technologies. The company’s mission is to translate its genome editing technology into a novel class of human therapeutics...

Vitruvius Therapeutics Inc.

Vitruvias is a generic pharmaceutical company which utilizes domestic and international partnerships to develop, manufacture, and market technically difficult generic products. Founded in 2013, the company’s primarily focus is on products in the generic sterile injectable market, semi-solid market, and selected high-value oral solids The Company recei...

Active Biotech

Active Biotech AB is a Swedish biotechnology company focused on the research and development of pharmaceuticals and vaccines. Their core competence is knowledge of the human immune system.

Centre for Molecular Medicine and Therapeutics (CMMT)

The Centre for Molecular Medicine and Therapeutics (CMMT) is dedicated to the practice of world class discovery research contributing to the fundamental knowledge in the determination and control of genetic susceptibility to disease. Among the unique advantages of the CMMT are flexibility, the ability to develop, evaluate and incorporate ideas, and to move rapidly into promising areas. The Centre ...

Acrongenomics Ins

The global trend towards miniaturization of devices could not leave the Life Sciences sector unaffected. The bringing together of different technologies like microelectronics, optics, mechanics, physics and molecular biology along with the miniaturization of fluidic and sensing devices makes possible the development of fully integrated, miniaturized diagnostic systems. Acrongenomics, Inc. and Mol...

Haug Partners LLP

Haug Partners LLP is a national law firm that provides integrated multidisciplinary legal services for life science and technology companies. With offices in New York, Washington, D.C., and Boston, and through working partnerships with firms in Germany, China, and Japan, Haug Partners has the resources, technical expertise, legal acumen, and business judgm...

Biocod

A Biocod é uma empresa de biotecnologia que presta serviços nas áreas de genética e biologia molecular. Fundada em fevereiro de 2000 a empresa, que conta com uma equipe técnica qualificada e experiente, rapidamente conquistou o mercado nacional devido à sua filosofia de trabalho: oferecer serviços com a mais alta qualidade. Os principais serviços prestados pela Biocod são os exames de inv...

AC Vaccine technology

The AC Vaccine technology is a therapuetic treatment based on the concept of haptenization. This idea has a long history, beginning with the work of the immunologist and Nobel laureate Karl Landsteiner in the 1920’s. He and other scientists showed in animal models that attaching a small chemical (a hapten) to a protein allowed that protein to be recognized by the immune system even if the anim...

Arcus Biosciences, Inc.

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies. Arcus has several programs targeting important immuno-oncology pathways, including a dual adenosine receptor antagonist and an anti-PD-1 antibody, both of which are in Phase 1 trials, as well as a small molecule inhibitor of CD73 and an an...

Vycellix, Inc.

Vycellix, Inc. is a closely-held biotechnology company advancing innovative products designed to enhance cellular therapies, facilitate manufacturing processes and optimize human immune response against disease with a focus on cancers.

Diaclone

Diaclone produces a large panel of monoclonals antibodies and kits to detect human, mouse and rat molecules playing key roles in the immune system (CDs, cytokines and adhesion molecules.

Gain Therapeutics SA

Gain Therapeutics is a preclinical stage biotech company developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx® technology. The company has several discovery programs in lysosomal storage diseases and CNS indications at various stages of dev...

Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Principal programs are directed toward supportive care, oncology and virology. Progeni...

Molecular Devices Corporation

Molecular Devices Corporation designs, develops, manufactures and markets proprietary, high-performance, bio-analytical measurment systems, including software and consumables, designed to accelerate and improve the cost effectiveness of the drug discovery and development process.

Beta-Cell

Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the highly specialized endocrine cells located in pancreatic islets and responsible for producing insulin. Beta-Cell has an advanced pre-clinical xeno-transplantation program based on its proprietary techno...

Aquila Diagnostic Systems Inc.

Aquila Diagnostic Systems Inc.’s patented Accutas technology allows gold-standard molecular diagnostic (DNA/RNA) tests to be performed at a veterinary clinic or in the field using non-standard mediums such as fecal material with a sample-to-results time of 2 hours or less. Accutas molecular diagnostic tests may be performed on any Aquila-certified ind...

Xagenic Inc.

Based in Toronto, Ontario, Xagenic is a privately held molecular diagnostics company developing a fully-automated molecular diagnostic platform that will enable lab-free testing with a time-to-result of 20 minutes. The company is developing a menu of infectious disease tests that will have a positive impact on patient care and reduce health care costs. The...

Speedel

Speedel is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. Our lead product candidate SPP100 (Aliskiren), the first-in-class renin inhibitor,...

Bioxyne

Bioxyne Limited (ASX:BXN) is an Australian immunotherapeutics business created in April 2012 through the reverse takeover of Probiomics (ASX: PCC) by privately held Hunter Immunology. The Company’s lead therapy, HI-164OV is based on the Company’s proprietary technology that uses the application of mucosal immunology to treat common human diseases.  HI-164OV, in Phase IIb clinica...

Lexigen Pharmaceutical Corporation

Lexigen Pharmaceuticals Corp. (formerly Fuji ImmunoPharmaceuticals Corp.) was founded in 1992. Lexigen is engaged in the development of drugs and genetically engineered products to treat cancer, immune system disorders, and other diseases.


More From BioPortfolio on "Immunotherapeutics Immune Checkpoint Inhibitor Effi 24th Molecular 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks